AI app aims to ease teen depression in hong kong schools

NCT ID NCT07704996

First seen Jul 15, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This trial tests whether an AI-enhanced mobile app called e-CAMP can improve mental well-being and reduce mild-to-moderate depression and anxiety in young adolescents aged 11 to 15. About 300 students from eight schools in Hong Kong will either use the app regularly for eight weeks or receive a standard health talk. Researchers will measure changes in depressive symptoms, mental health knowledge, and smartphone habits to see if the app offers a practical tool for schools.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an AI-enhanced mobile application called e-CAMP
What this could lead to
If effective, this app could offer a scalable, low-cost way to support mental health and reduce mild-to-moderate depression in young teens.
What could go wrong
This is a relatively small trial in one city, and the app's benefits may not extend to other settings or more severe cases. Results depend on consistent app use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION AND/OR ANXIETY IN THE MILD-TO-MODERATE RANGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression mixed anxiety and depressive disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tung Wah College

    Hong Kong, Hong Kong, 00, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.